Zeke Capital Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $297K | Sell |
|
|||||
|
2022
Q2 | $312K | Sell |
|
|||||
|
2022
Q1 | $383K | Sell |
|
|||||
|
2021
Q4 | $367K | Buy |
|
|||||
|
2021
Q3 | $384K | Buy |
|
|||||
|
2021
Q2 | $337K | Buy |
|
|||||
|
2021
Q1 | $290K | Buy |
|
|||||
|
2020
Q4 | $254K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $234K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $748K | Buy |
|
|||||
|
2018
Q4 | $421K | Buy |
|